Qualified Participants Must:
• Subjects have to be between the ages of 18 - 75 years of age
•
Must be diagnosed with ulcerative colitis for 90 days prior to receiving study medication and have to had an inadequate response to corticosteriods, immunosuppressants, and/or biologic therapies
Qualified Participants May Receive:
Those who qualify may receive compensation for there time and travel.